Stockscreener 앱 받기
32.40
0.59%
0.19
시간 외 거래:
32.40
전일 마감가:
$32.21
열려 있는:
$32.305
하루 거래량:
637.99K
Relative Volume:
0.71
시가총액:
$2.57B
수익:
$517.15M
순이익/손실:
$66.35M
주가수익비율:
39.45
EPS:
0.8212
순현금흐름:
$126.63M
1주 성능:
-1.19%
1개월 성능:
-11.45%
6개월 성능:
-10.52%
1년 성능:
+9.61%
1일 변동 폭
$32.00
$33.54
1주일 범위
$29.45
$33.54
52주 변동 폭
$22.61
$50.71
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
32.40 | 2.56B | 517.15M | 66.35M | 126.63M | 0.8212 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Underweight |
| 2025-10-20 | 개시 | Canaccord Genuity | Hold |
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Veracyte (VCYT): Needham Reaffirms "Buy" Rating with $48 Price T - GuruFocus
Needham Maintains Veracyte(VCYT.US) With Buy Rating, Maintains Target Price $48 - Moomoo
Needham reiterates Veracyte stock rating on bladder cancer test plans - investing.com
Cathie Wood’s ARK buys OpenAI Group stock, sells Veracyte shares By Investing.com - Investing.com India
Cathie Wood’s ARK buys OpenAI Group stock, sells Veracyte shares - Investing.com
Is Veracyte Stock a Smart Addition to Your Investment Portfolio at This Time? - bitget.com
Is Veracyte Stock the Right Pick for Your Portfolio Now? - Yahoo Finance Singapore
MACD Signal: Is Veracyte Inc stock a value trap2026 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
VCYT SEC FilingsVeracyte 10-K, 10-Q, 8-K Forms - Stock Titan
Veracyte price target lowered to $45 from $50 at Guggenheim - TipRanks
Exit Recap: Is Veracyte Inc a strong candidate for buy and hold2026 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Guggenheim Maintains Buy Rating, Lowers Price Target on VCYT to $45 | VCYT Stock News - GuruFocus
Veracyte (VCYT) down 15.4% since last earnings report: Can it rebound? - MSN
Veracyte (NASDAQ:VCYT) Price Target Lowered to $45.00 at Guggenheim - MarketBeat
Guggenheim Maintains Veracyte(VCYT.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
Does Veracyte (NASDAQ:VCYT) Deserve A Spot On Your Watchlist? - Moomoo
Veracyte (NASDAQ:VCYT) Shares Down 9.2%What's Next? - MarketBeat
Vanguard disaggregates reporting; lists zero holdings in Veracyte (VCYT) - Stock Titan
Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Volatility Watch: Is Veracyte Inc stock a top performer YTDPortfolio Return Report & Expert Approved Trade Ideas - baoquankhu1.vn
Veracyte, Inc. $VCYT Shares Sold by Nordea Investment Management AB - MarketBeat
Veracyte, Inc. $VCYT Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Update Report: Should value investors consider Veracyte Inc2026 Trade Ideas & Weekly High Return Forecasts - baoquankhu1.vn
Veracyte (VCYT) Chief Dev and Tech Officer files initial Form 3 - Stock Titan
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Veracyte Taps Kevin Haas To Guide AI Push And Undervalued Shares - Sahm
TGI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Westview Management dba Westview Investment Advisors Invests $1.38 Million in Veracyte, Inc. $VCYT - MarketBeat
Does Veracyte (VCYT) offer both strength and opportunity? - MSN
Veracyte Names Kevin Haas as Chief Development and Technology Officer - StreetInsider
Breakouts Watch: Can Veracyte Inc expand into new marketsQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
How Veracyte’s New AI-Focused CTO Role At Veracyte (VCYT) Has Changed Its Investment Story - simplywall.st
Veracyte appoints Kevin Haas as chief development officer By Investing.com - Investing.com Australia
Veracyte CFO Chambers sells $662k in VCYT stock - Investing.com Nigeria
Veracyte (VCYT) Appoints New Chief Development and Technology Of - GuruFocus
Veracyte names Kevin Haas as Chief Development and Technology Officer - TipRanks
Veracyte names Kevin Haas as chief development and technology officer - marketscreener.com
Veracyte Names Kevin Haas As Chief Development And Technology Officer - TradingView
Veracyte Appoints Kevin Haas as Chief Technology Leader - TipRanks
Veracyte Appoints Kevin Haas as Chief Development and Technology Officer - marketscreener.com
Veracyte appoints Kevin Haas as chief development officer - Investing.com
Veracyte (NASDAQ: VCYT) hires Kevin Haas as Chief Development and Technology Officer - Stock Titan
Veracyte, Inc. Appoints Kevin Haas as Chief Development and Technology Officer, Effective March 24, 2026 - marketscreener.com
Iron Triangle Partners LP Purchases New Position in Veracyte, Inc. $VCYT - MarketBeat
Fred Alger Management LLC Takes $26.35 Million Position in Veracyte, Inc. $VCYT - MarketBeat
Bamco Inc. NY Decreases Stake in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. $VCYT is ArrowMark Colorado Holdings LLC's 7th Largest Position - MarketBeat
Veracyte Inc Stock (ISIN: US92347M1009) Holds Steady Amid Analyst Downgrade and Mixed Signals - AD HOC NEWS
Veracyte (NASDAQ:VCYT) Downgraded by Zacks Research to "Hold" - MarketBeat
Veracyte, Inc. $VCYT Stock Holdings Lifted by First Trust Advisors LP - MarketBeat
Veracyte (VCYT) CAO awarded 10,525 RSUs in new equity grant - Stock Titan
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
자본화:
|
볼륨(24시간):